Pharma Blockchain 2019
Share
Now
WHY SHOULD YOU ATTEND?
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
Event Speakers
HEATHER L F
Healthcare Global
HEATHER L F
Healthcare Global
HEATHER LEIGH FLANNERY, Co-Founder & Board Chair, Blockchain in Healthcare Global - IEEE ISTO (USA)
PHILIPPE G
IoTSG (Singapore)
DAVE EBBITT
Medicalchain
“Potential impact of Blockchain in Pharma & Healthcare”
Event Schedule
Meet and to network with your conference colleagues.
08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.
09:30 – Chairperson opening remarks
LOY LOBO, President Elect, Digital Health Section, Royal Society of Medicine, London
MARKET TRENDS & WAY FORWARD
09:40 – “The pharmaceutical world of tomorrow with AI/LM…” in order to have a personalized medication…
EDITH LECOMTE NORRANT, CEO & CSO, Legomedic
STRATERGY & IMPLEMENTATION
10:20 – Blockchain in Healthcare - PhUSE industry working group
AJI BAROT, VP Pharma (EMEA), Medisafe
10:50 – Morning Coffee/Tea & Discussion
11:20 – The need for decentralization in closed loop supply chain management
• A closer look at closed loop supply chain processes of personalized medicine
• How distributed ledger technology can secure and optimize the chain of identity and custody of personalized medicine
• Utilizing blockchains to orchestrate cross-company manufacturing processes
• Electronic health records and the GDPR: Blockchain alone will not help
• Post commercialization challenges and the path to real world data
CHALLENGES & OPPORTUNITIES
11:50 – Keynote Panel Discussion: Challenges and Opportunities – Blockchain Technology
• Outlining the resource, technology, awareness and financial challenges that may rise in implementing blockchain technology
• Why blockchain is a must to learn technology?
• Possibilities with blockchain – Why you shouldn’t miss out
• What is it with blockchain that will make us to survive?
• Create new possibilities for existing technology to reach its full potential?
• How blockchain can be developed, and how it can develop us.
• Highlighting key recommendations
• Where is blockchain heading?
Moderator
HEATHER LEIGH FLANNERY, Co-Founder & Board Chair, Blockchain in Healthcare Global - IEEE ISTO (USA)
Panellists
ANAND DAS, Regional Client Partner, Pfizer
PHILIPPE GERWILL, Industry Advisor, IoTSG (Singapore)
PASCAL BOUQUET, Global Head Technology and Architecture for Global Drug Development, Novartis
DISA LEE CHOUN, Head of Innovation, Global Clinical Services & Operations, Development and Medical (Patient Value) Practices, UCB Celltech
12:30 – Networking luncheon
BLOCKCHAIN, IOT, AI, BIG DATA
13:50 – Panel Discussion – How can Blockchain transform pharma with AI, IoT and Big Data?
• How blockchain could revolutionise pharmaceuticals?
• How can AI and Blockchain work together?
• AI Powered DAOs (Decentralized Autonomous Organizations)
• Blockchain for startups – Where to start?
• IoT and AI enabled devices
• Decentralized data sharing
• Audit trails on data
Moderator
ABRAHAM JOSEPH, Founder & Editorial Director, IOT Insights
Panellists
MUNTHER BAARA, Head, New Clinical Paradigm, Pfizer (USA)
EDDIE GUZDAR, Medical Head of Neuroscience, Sanofi Genzyme UKIE
STEWART SOUTHEY, Founder, Catena Consulting (Consultant Anaesthetist, NHS)
SIDDHI TRIVEDI, Founder, Beowulf Proof Work
ANDREW CAMPBELL, Head of Supply Chain Solutions, Applied Blockchain
AJI BAROT, VP Pharma (EMEA), Medisafe
13:50 – Criteria to qualify as compassionate use
• Patients suffering from life threatening diseases, or diseases causing serious permanent disability
• No comparable or satisfactory therapy available to diagnose, monitor, or treat the patient’s disease or condition.
• That the probable risk to the person from the investigational product is not greater than the probable risk from the disease or condition.
• Sufficient evidence of the safety and effectiveness of the investigational product to support its use in the particular circumstance;
• Investigational product will not interfere with the initiation, conduct, or completion of clinical investigations to support marketing approval
• The patient is unable to participate in a clinical trial.
SAKHARAM GARALE, Head South-East Asia Operations ACMA
14:40 – Blockchain for life sciences, data donation and maybe Blockchain for clinical supplies
MUNTHER BAARA, Head, New Clinical Paradigm, Pfizer (USA)
15:20 – Afternoon Tea/Coffee
MANAGING DATA
15:40 – Tokenomics of Health Data
• Tokens as incentives to digitize health data
• Health data as the future currency in healthcare systems
• How to build a decentralized system for exchange of health data
• Access to potential research participants on the HIT platform
16:10 - The Blockchain Readiness Framework for Protected Health Information: a Roadmap to Adoption at Scale
• Understand a new three-staged mental model for assessing blockchain use-case readiness in healthcare and life sciences;
• Distinguish between value creation contexts for clinical trails, and ethically using clinical trials to bridge regulatory uncertainty.
• Explore the near-term and long-range potential of tokenization for capital formation, clinical research, and real-world evidence;
HEATHER LEIGH FLANNERY, Co-Founder & Board Chair, Blockchain in Healthcare Global - IEEE ISTO (USA)
16:40 – Chairperson’s closing remarks and end of conference
16:50 - 18:00 - Networking Drinks - Take your discussions further & build new relationships in a relaxed & informal setting
08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.
09:30 – Chairperson opening remarks
LOY LOBO, President Elect, Digital Health Section, Royal Society of Medicine, London
SECURITY - 2022
09:40 – “The Future of Identity Management with Blockchain”
PHILIPPE GERWILL, Industry Advisor, IoTSG (Singapore)
10:20 – The new Web: blockchain concept and criteria. Could it be a possible Pharma solution?
• Big Data – Gamification - IOT – Retail and Blockchain First step to the Internet of value
• Blockchain and Pharma several possible solutions: new technologies – AI/machine learning in pharmacovigilance and several new options
STEFANIA ALVINO, MultiChannel Manager, Daiichi Sankyo Italia
10:50 – Morning Coffee/Tea & Discussion
11:20 – Can Blockchain increase trust in clinical trials?
• Brief introduction of what has already been done in the field with examples, protocol storage, subjects selection and genomics.
• e-Health and subjects selection in review, a detailed review of possible applications and benefits for cost and time reductions in Clinical trials.
NATALIA MONTEIRO, Clinical Trial Budget & Metrics Mgmt. Analyst - Vaccines Business Unit, Takeda Pharmaceuticals
12:00 – Keynote Panel Discussion - Strengths & Potential road blocks for adoption of Blockchain
• Benefits & Roadblocks to Blockchain adoption
• Why Healthcare and Pharma industry should care about blockchain?
• What’s the primary challenge to Blockchain technology?
• What’s holding Blockchain back from large-scale adoption? How to overcome this?
• Preparing for the Next Phase of Digital Growth
• Prevention of counterfeit drugs
• Potential regulatory roadblocks
Moderator
LOY LOBO, President Elect, Digital Health Section, Royal Society of Medicine, London
Panellists
SUSAN TILLMANN, Head of Innovation Global Manufacturing & Supply, Takeda Pharmaceuticals
EDWARD BUKSTEL, CEO, Clinical Blockchain (USA)
DAVE EBBITT, Health Informatics Manager, Medicalchain
12:40 – Networking luncheon
13:50 – Legal and compliance implications of Blockchain in Pharma industry
EVGENY TILEZHINSKY, Law and Compliance Lead for the Central & Eastern Europe, Bristol-Myers Squibb
14:30 – The Code of Life - Blockchain & the Future of Genomics
• What the future of Genomics look like and what it means for society
• Problems that could arise through the development in the Genomics space
• How Blockchain can revolutionize the Genomics industry
• What the Future Will Look Like & How We Can Accelerate that Reality
RIYA KARUMANCHI, Innovator / Founder & CEO, The Knowledge Society (TKS) / SmartCane (Canada)
15:10 – Personal care records - the essential link between Pharma and consumer
• No-one wins:
if the consumer does not collect their medication
if the consumer does not take their medication
if the consumer does not renew their medication
• The consumer is key.
• Pharma needs a 1:1 relationship with the consumer.
• Blockchain personal care records can enable that.
STAN SHEPHERD, CEO, Instant Access Medical (IAM), (Former GP and CQC GP Inspector)
15:40 – Afternoon Tea/Coffee
16:00 – BlockChain and Healthcare: The Really Big Picture
• Blockchain gives the opportunity to build a network of data for health and pharma. Like all networks, the value of the network goes up to an exponential function of the number of nodes on the network.
• So the more all encompassing the network, the more patients and types of information indexed by a chain, the move valuable it will be. Fragmentation in blockchain will decrease value and utility, exponentially.
• It is temping to build chains for specific purposes - this creates a faster payback and a more conservative scope - like an organization that has all it’s information in a fining cabinet rather than from a network of networks like the internet.
• It is a well established corollary of the network effect that we tend to overestimate what can be achieved in two years and vastly underestimate what can be achieved in ten - se we tend to cap the system performance and architecture to match the two year expectation not the ten.
• There are hundreds of blockchain projects moving in on the Pharma, Medical and Healthcare Sectors, but like previous software projects in the fields, outcomes and resulting benefits seem likely to be fragmented. So what can we do? Can we optimise? Is there an optimum architecture? A Pareto solution?
• Here are some solutions.
16:30 - 16:40 - Chairperson’s closing remarks and end of the conference
Share
Now
Event Sponsors & Partners
Virtue Insight
CONCEPTUALISED BY
Virtue Insight
CONCEPTUALISED BY
Virtue Insight equips business professionals around the world with the latest indepth industry knowledge and provides networking opportunities in the telecom, infrastructure and pharmaceutical industry. Our aim is to provide a platform to share knowledge and insights and provide our event attendees to network effectively and deliver maximum ROI by make new business alliances. We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.
Our motto is to offer our customers the expertise and connections for a profitable business. Our events encompass an optimum chance to gain maximum value in terms of networking and an opportunity to sponsor and exhibit to attract new business alliances.
Testimonials
Cisco Business Ops Manager
Product Support Manager -Fusion SCM (OM/IoT) Oracle
Service Delivery Manager Robert Bosch Engineering and Business Solutions
Principle Consultant Mercedes-Benz Research and Development
Get Involved
Speaking Opportunities
Fen Castro
fen@virtueinsight.co.in
+91 44 42108101
Sponsor / Exhibit / Delegate Bookings
Piyush Patel
piyush@virtueinsightevents.com
+44 20 3509 3779
